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ABSTRACT

Isokinetic Knee Strength in Females with Fibromyalgia

By
Flora F. Shafiee

Objectives: To compare knee flexors and extensors muscle strength, total work, and
power between females with fibromyalgia (FM) and matched healthy controls.
Methods: This is the first study to measure knee muscle power and total work in
females with FM. Thirty-one females with FM and thirty-one healthy females completed
isokinetic testing of knee flexors and extensors of their dominant leg using a Cybex Norm
Isokinetic Dynamometer. Two knee muscle groups (flexors and extensors) at two angular
velocities (607sec and 1807sec) were tested for both groups. Both muscle groups were
assessed continuously using five reciprocal concentric-concentric cycles, followed by five
eccentric-eccentric cycles.
Results: Females with FM exhibited significant decreases in voluntary muscle strength
ranging from 18%-24% and average power ranging from 25%-30%, more pronounced for
knee flexors than knee extensors. The strength and power deficits were not uniform
during all test arrangements: 1) Maximum eccentric muscle strength for knee flexors and
extensors at an angular velocity of 60 /sec in females with FM was reduced compared to
the control group (p = .005 and .007, respectively), 2) Maximum concentric muscle
strength for knee flexors at an angular velocity of 180 /sec in females with FM was
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reduced compared to the control group (p = .002), and 3) Average power for knee flexors
at an angular velocity of 607sec for eccentric muscle action and 1807sec for concentric
muscle action in females with FM was reduced compared to the control group (p =.006
and .001, respectively). No differences in total work at the two different velocities for the
two muscle actions were found.
Conclusion: We found decreased knee muscle strength and power in females with FM
compared to healthy females. This may be due to muscle soreness from unhealed
microtraumas, slow deformation of collagen and periarticular connective tissue of the
knee joint, hypoxia, or decreased content of high energy metabolites.

Fibromyalgia (FM) syndrome is a chronic pain disorder of unknown etiology
characterized by widespread musculoskeletal aches and pains, stiffness, and general
fatigue.1-2 Fibromyalgia syndrome is similar to other chronic idiopathic pain syndromes.
but can be differentiated by the identification of palpatory tender points at specific
anatomic sites through palpatory inspection.3'5 The role of physiological, psychological,
or deconditioning factors in regards to FM are not agreed on.4 The etiopathogenesis and
pathophysiology of FM are poorly understood.5 Whether peripheral or central
mechanisms are involved remains debated.6 Patients with FM typically report that their
muscular performance is inhibited by pain, weakness, and activity-induced muscle
fatigue.
A reduction of maximal voluntary isometric and isokinetic strength in the
quadriceps muscle in patients with FM, secondary to primary muscle dysfunction, has
been reported by Jacobsen et al.7 Similar results were reported by Lindh et al8 and
others. 9-14 Hakkinen et al,15 however, were unable to confirm these findings. In their
study, females with FM did not demonstrate lower dynamic or isometric muscle strength
characteristics compared to matched healthy control subjects. Hakkinen et al15 also
supports the hypothesis that patients with FM have normal muscle structure and
neuromuscular function. Similar results of normal muscle strength have been reported by
Megshoel et al16 and Stokes et al.17 The purpose of this study was to compare knee flexor
and extensor voluntary muscle force development in fibromyalgia and healthy subjects
for the following conditions: 1) Concentric and eccentric muscle activity, and 2) At two
angular velocities, 607second and 1807second.
3
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Methods

Subjects
Females with FM were referred from one physician at the Veterans
Administration Hospital and two physicians from the Rheumatoid Clinic at the Loma
Linda University Medical Center, both in Loma Linda, California. All subjects with FM
met the American College of Rheumatology criteria for the diagnosis of FM by exhibiting
at least 11 out of the 18 tender points and wide spread pain in all four quadrants of the
body for a minimum of three months.5 Subjects with FM were matched by age to healthy
subjects, at least within the same decade. Healthy females were obtained from the
community at large.
Females from both groups were living independently in their homes or
apartments, were between 24 and 70 years of age, had no injury or deformity of their
dominant leg, were able to walk independently without limping, and were able to walk
while performing activities of daily living. Subjects having chronic co-morbidities, such
as cardiopulmonary, orthopedic, or neurological pathologies, were excluded from the
study. Subjects gave informed consent before being scheduled to participate in the
isokinetic test. Thirty-one female volunteers with FM and 31 healthy, age-matched
female volunteers completed isokinetic testing of the knee flexors and extensors of their
dominant leg. All subjects were able to follow instructions and properly complete the
test.
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Instruments
The Cybex Norm Isokinetic Dynamometer (CNID) is a single-chair rehabilitation
and testing system. Isokinetic testing was chosen for its ability to produce a constant
speed with accommodating resistance throughout the entire range of motion. Subjects
can never exceed the fixed speed, regardless of how much effort they exert. The amount
of resistance provided by the apparatus always matches the amount of force the subject
exerts. Increased or decreased force production by the subject results in increased or
decreased resistance, not faster or slower velocity. Therefore, decreased force production
by the subjects due to pain is always accommodated.
Procedures
The subjects were positioned on the CNID with their lumbar spine against a back
support, keeping their hip angle at 80°. Stabilizing belts were secured across the lap.
shoulders, and thigh of the dominant leg, defined as their leg of preference used to kick a
ball. Subjects were allowed to grasp the dynamometer seat’s arm during the test. Two
knee motions (flexion and extension) at two angular velocities (607second and 180°
/second) were tested during one session of approximately 45 minutes duration. The
slow-angular velocity test (607second) provides a good indication of the subject’s ability
to withstand compressive forces. It also produces the best interpretation of the torque
curve shape. The high speed testing (180 /second) was chosen for its
ability to assess power.
The dynamometer eliminated torque overshoot and corrected all torque measures
for the effects of gravity on the lower leg. The range of motion was set from 100° of knee
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flexion to 0°. Subjects completed at least one sub-maximal practice routine and one
maximal practice routine prior to testing. They were then asked if they believed they
could perform the test procedure maximally. Any subject requesting additional practice
was allowed to do so. Both muscles groups (flexors and extensors) were assessed
continuously using five reciprocal concentric/concentric cycles and five reciprocal
eccentric/eccentric cycles without a pause between the two phases of muscle activation.
Verbal encouragement was given during the recorded trials. A two minute rest period
was inserted between the different knee speed conditions.
The testing protocol for knee flexors and extensors was as follows: 1) Isokinetic
concentric/concentric at an angular velocity of 607second, 2) Isokinetic concentric
/concentric at an angular velocity of 180 “/second, 3) Isokinetic eccentric/eccentric at an
angular velocity of 60°/second, and 4) Isokinetic eccentric/eccentric at an angular
velocity of 180 /second.
Data Analysis
The level of significance was set at .01 because of multiple comparisons. Peak
torque per percentage body weight for knee flexors and extensors was calculated by
dividing the peak torque for the speed by the subject’s body weight and expressing it as a
percentage. Total work per percentage body weight for knee flexors and extensors was
calculated by dividing the total amount of work in foot-pounds (ft-lbs) or joules for the
listed speed by the subject’s body weight and expressing that value as a percentage.
Average power and best work repetition (BWR) per percentage body weight for
knee flexors and extensors were also calculated. Average power is an expression of work
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per unit of time and is an accurate indicator of the subject’s actual work rate. The amount
of work performed in the BWR was divided by the actual contraction time, with the unit
measure in Watts. The average power value was then divided by the subject’s body
weight, and expressed as a percentage.
Means and standard deviations were calculated for all isokinetic muscles
variables (flexors and extensors) and the two different muscle contractions at two
different angular velocities (607second and 1807second) for both FM and healthy
females. Independent t-tests were used to compare females with FM and healthy females
for each of the muscle contraction and angular velocity variables.
Results
Sixty-two subjects (31 females with FM, 31 age-matched healthy females) were
recruited for the study. The mean age of the females with FM was 51.3 years (SD =
10.1), while the mean age of the healthy females was 51.0 years (SD = 11.0). The mean
weight of the FM females was 155.3 pounds (SD = 28.7), while the mean weight of the
healthy females was 150.6 pounds (SD = 28.2).
Tables 1-3 show the means and standard deviations for peak torque, total work,
and average power per percentage body weight for knee flexors and extensors at two
different angular velocities (60 /second and 180 /second) and with two different muscle
actions (concentric and eccentric). Some isokinetic variables were significantly lower in
females with FM than in the healthy females. Reductions were more marked for the knee
flexors than for the knee extensors. The FM group exhibited a significant reduction of
isokinetic muscle strength and power ranging from 18%-30%. Mean peak torque per
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percentage body weight of knee flexors and extensors at an angular velocity of 607second
was significantly lower for females with FM compared to healthy females ( p = .005 and
.007, respectively) for only the eccentric muscle action (Table 1).
Table 1.
Peak Torque per Percentage Body Weight for Knee Flexors and
Extensors

Variables

FM
(n =31
Mean (SD)

Healthy
(n = 31
Mean (SD)

P-value

Flexors
60°/Sec
Concentric
Eccentric

25.3 (8.6)
-39.4(10.9)

30.3 (11.4)
-48.1 (13.4)

.005

180°/Sec
Concentric
Eccentric

16.5 (7.8)
-36.9(10.7)

21.8 (7.1)
-44.1 (11.6)

.002
.02

Extensors
60°/Sec
Concentric
Eccentric

43.6(12.0)
-53.4(17.9)

50.0(15.6)
-68.4 (22.5)

.007

180°/Sec
Concentric
Eccentric

28.5 (9.9)
-54.7(18.1)

31.8 (8.9)
-64.4 (22.0)

.16
.06

.04

.06

(SD) Standard deviation
(FM) Fibromyalgia
(n) Number of subjects

The females with FM exhibited a significant reduction of isokinetic muscle strength for
knee flexors and extensors of 18% and 22%, respectively, compared to healthy females.
Similar results were shown for mean peak torque per percentage body weight of knee
flexors at an angular velocity of 1807second for concentric muscle action only.
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Mean peak torque per percentage body weight was significantly lower for FM females
compared to healthy females (p = .002). The females with FM exhibited a significant
reduction of isokinetic muscle strength for knee extensors by 24% compared to healthy
females. Mean total work per percentage body weight of knee flexors and extensors at
angular velocities of 60 /second and 1807second for both concentric and eccentric muscle
action were not significantly different between groups (Table 2).
Table 2.
Total Work per Percentage Body Weight for Knee Flexors and
Extensors

Variables

FM
(n =31
Mean (SD)

Healthy
(n = 31
Mean (SD)

P-value

Flexors
60°/Sec
Concentric
Eccentric

29.9(11.2)
-41.6(12.2)

36.8 (14.8)
-51.4(14.2)

.42
.89

180°/Sec
Concentric
Eccentric

19.3 (10.5)
-38.3 (12.3)

26.6 (9.5)
-46.4(13.9)

.06
.93

Extensors
607Sec
Concentric
Eccentric

48.2(12.1)
-57.8(19.6)

55.1 (17.4)
-70.7 (22.0)

.44
.70

1807Sec
Concentric
Eccentric

33.5 (11.9)
-60.7(18.0)

36.8(10.9)
-71.1 (22.7)

.54
.72

(SD) Standard deviation
(FM) Fibromyalgia
(n) Number of subjects
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Mean average power per percentage body weight of knee flexors at an angular velocity of
60 / second for only eccentric muscle action, and an angular velocity of 180 /second for
only concentric muscle action were significantly lower (p = .006 and .001, respectively)
for females with FM compared to healthy females (Table 3).
Table 3.
Average Power per Percentage Body Weight for Knee Flexors and
Extensors

Variables

FM
(n =31
Mean (SD)

Flealthy
(n = 31
Mean (SD)

P-value

Flexors
607Sec
Concentric
Eccentric

20.5 (8.7)
-21.9 (7.2)

25.8(11.5)
-29.3 (12.0)

.006

1807Sec
Concentric
Eccentric

34.4 (20.5)
-41.3(19.3)

49.2(19.7)
-42.1 (31.4)

.06
.93

Extensors
607Sec
Concentric
Eccentric

35.3(11.0)
-31.2(12.8)

39.1 (14.1)
-39.6(15.1)

.24
.04

1807Sec
Concentric
Eccentric

63.0 (26.3)
-76.3 (37.0)

74.5 (32.6)
-79.2 (46.4)

.11
.80

.03

(SD) Standard deviation
(FM) Fibromyalgia
(n) Number of subjects

The females with FM exhibited a significant reduction of isokinetic muscle power for
knee flexors of 25% and 30% compared to healthy females. Mean average power per
percentage body weight of knee extensors at angular velocities of 60 /second and
180/second for both concentric and eccentric muscle activity, however, were not
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significantly different between groups.
In addition, while not significantly different, mean peak torque per
percentage body weight of knee flexors at an angular velocity of 607second for concentric
muscle action was lower (p =.04) for females with FM when compared to healthy females
(Table 1). Mean peak torque per percentage body weight of knee flexors at angular
velocity of 180 /second for eccentric muscle action was lower (p =.02) for females with
FM compared to healthy females (Table 1). Mean average power per percentage body
weight of knee flexors at an angular velocity of 60 /second for concentric muscle action
was lower (p =.03) for females with FM compared to healthy females (Table 3). Mean
average power per percentage body weight of knee flexors at an angular velocity of
180 /second for eccentric muscle action was lower (p =.04) for females with FM
compared to healthy females (Table 3). Average power per percentage body weight of
knee extensors at an angular velocity of 60 /second for eccentric muscle action was lower
(p =.04) for females with FM compared to healthy females (Table 3).
Discussion
Our study focused on evaluating muscle strength, total work, and power for knee
flexors and extensors with two different muscle actions (concentric and eccentric) at two
angular velocities (60 /second and 180 /second). Decreased muscle strength and power
were more noticeable in knee flexors than knee extensors. Eccentric muscle action was
more involved than concentric action, in spite of the fact that eccentric action, as
compared to concentric action, is the primary muscle action of walking. The study
revealed that: 1) Maximum muscle strength of knee flexors and extensors at an angular
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velocity of 607second for eccentric muscle action in females with FM was reduced
compare to those of age-matched healthy females, 2) Maximum muscle strength of knee
flexors at an angular velocity of 1807second for concentric muscle action in females with
FM was reduced compare to those of age-matched healthy females, and 3) Average power
of knee flexors at an angular velocity of 607second for eccentric muscle action and
180 /second for concentric muscle action in females with FM was reduced compare to
those of age-matched healthy females. We did not find differences in total work for knee
flexors and extensors at the two different velocities (60 /second and 180 /second) for the
two muscle actions (concentric and eccentric). No differences in muscle power were
found for knee extensors at the two different velocities (60 /second and 180 /second) for
the two muscle actions (concentric and eccentric) when comparing females with FM to
age-matched healthy females.
Isokinetic knee muscle strength parameters were significantly lower in the
females with FM than for healthy females with differences ranging from 18%-24%.
Average power of knee flexors were considerably lower by 25% and 30% compared to
the healthy females. According to Philadelphia Panel Evidence,18 15% or greater
differences compared to control are clinically important based on panel expertise and
empiric results. Several studies have evaluated peak torque for knee flexors and
extensors at different angular velocities for concentric muscle action. 7-8,11-12 Our study
showed results similar to Norregaard et al.9 The patients with FM in their study also
exhibited a significant reduction in voluntary muscle strength of the knee and elbow
flexors and extensors by 20%-30%. The coefficient of variation, however, was higher

13

among patients, thus indicating lower effort, which they could not attribute to
psychopathology.
Our study also supported a study by Jacobsen et al.7 Maximum voluntary
isokinetic contractions of the right quadriceps were performed with superimposed
transcutaneous electrical stimulation. They found that patients with primary fibromyalgia
had a lower maximum voluntary muscle strength than healthy subjects. They reported
that isokinetic muscle strength was 45% lower in the patient group compared to healthy
subjects. They suggested that reduced maximum voluntary muscle strength is due to
either pain inhibition on a conscious or unconscious level. Borman et al11 evaluated the
relationship between quadriceps muscle performance in patients with FM and pain
severity, and compared the results with healthy control subjects. They found that
isokinetic peak torque of the quadriceps at low speed was significantly lower in patients
compared with the control group. There was no correlation between muscle performance
and clinical findings, including pain severity, number of tender points, and number of
associated symptoms. They related the decrease in muscle performance to a reduced
energy supply in initiating a standardized period of activation, that might be due to pain,
fear of pain, fatigue, or psychological status.
In our study, the results of decreased peak torque per percentage body weight in
females with FM were similar to the findings of Borman et al11 for knee flexors and
extensors at low angular velocity for only eccentric muscle action. Our study was
different from Borman et al,11 in that peak torque per percentage body weight for knee
flexors was also decreased at high speed, however, only for concentric muscle action.
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Maquet et al12 determined decreased maximal concentric isokinetic muscle
strength of the knee flexors more than extensors in the FM group compared to healthy
subjects. The decreases were more marked during aerobic than during anaerobic
exercise, and for the knee flexors than for the knee extensors. Our study supported the
findings of Maquet et al12 in that knee flexors were more involved than knee extensors.
Eccentric muscle action, however, was more involved than concentric muscle action at
low speed. Lindh et al8 reported a significant reduction of knee extensors and flexors
muscle strength in isometric, concentric, and eccentric tests in comparison with controls.
In that study, as well as in the present study, maximum peak torque was less reduced for
eccentric than concentric muscle action.
Two studies were found that contradict the findings of our study. 15,19 Hakkinen et
al15 recorded maximal voluntary bilateral concentric and isometric force, force time
(force produced during the first 500ms) variables of the leg extensors, and maximal
unilateral isometric force of the knee flexors using a David-210 dynamometer.
Electromyographic activity was recorded for the vastus medialis, vastus lateralis, and
biceps femoris. At base line, the mean maximal concentric leg extension forces and mean
maximal isometric force levels of the leg extension and knee flexion actions did not differ
between the FM and healthy groups. The mean maximal rates of the force development,
the forces produced in 500 ms, and relaxation times of the leg extensors did not differ
between the groups. They also found that heavy resistance fatigue loading led to
considerable and comparable acute fatigue in the neuromuscular performance in both FM
and healthy group subjects. Simms et al19 agreed with Hakkinen et al.15 They reported no
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differences in isometric muscle strength of the upper trapezius and tibialis anterior
muscles between FM and healthy groups. Their study demonstrated that muscle energy
metabolism in FM syndrome is no different than that in sedentary controls.
The differences between our study and both Simms et al19 and Hakkinen et al15
could be related to several factors. We recruited a larger size sample (31 subjects with
FM, and 31 healthy subjects), whereas, Simms et al19 only recruited 13 subjects with
FM and 13 healthy subjects. Hakkinen et al15 recruited only 11 subjects with FM and 12
healthy subjects. Our patients with FM were not able to participate in any sport activities
prior to the study secondary to pain in all four quadrants of their body, whereas, patients
with FM from the other two studies were involved with habitual physical activities
(walking, swimming, biking, skiing), and aerobic exercises before the beginning of their
study, which could make a difference. We used the CNID to measure muscle strength,
total work, and power, whereas, Simms et al19 used phosphorus magnetic resonance
spectroscopy (31 P-MRS). 31 P-MRS is used to provide a noninvasive approach to measure
important metabolites in muscle energy metabolism, such as phosphocreatine, inorganic
phosphate, and intracellular muscle PH. 20-24
Hakkinen et al15 based their findings for isometric extension actions of the leg
muscles on electromyography. Isometric parameters could be different than isokinetic
parameters due to different modes of testing, plus the fact that electromyographic testing
measures motor unit recruitment. Nonexistence of such problems does not indicate
normal muscle strength, however, especially when other contributing factors are
involved. Among such factors are decreased flexibility of the muscles/connective tissue,
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and decreased energy metabolites. All previous studies that supported our findings used
isokinetic dynamometers. 7-9,11-12
There was no proof in our study or both previous studies that patients were
performing maximum muscle action, in spite of the encouragements that were given to
the subjects. 15,19 Subjects may have thought that they did the best effort possible. Pain or
decreased flexibility of muscles or connective tissue, however, could have prevented
them from performing maximum muscle action. We divided peak torque, total work, and
average power by the subject’s body weight and expressed it as percentage to control
weight as an extraneous variable, which was different than the previous two studies.
Muscle mass, however, may differ between groups. We were unable to get body height
data to compare mean height for each group.
Elert et al25 related poor muscle performance in subjects with FM to an inability
to relax between repetitive movements, which may expose patients to increased muscle
pain later in life. They believe that poor muscle performance is the result of hypoxia,
rather than of a reduction in dynamic muscle strength and endurance. Backman et al26
also reported a lower relaxation rate in subjects with FM than in healthy controls. In their
study, subjects with FM had signs of hypoxia and decreased content of high energy
metabolites, factors which cause a low relaxation rate. 27-28
In our study, the fact that decreased strength of knee flexors and extensors for
eccentric muscle action was more pronounced than concentric muscle action could be
related to increased muscle soreness. Muscle soreness is usually associated with
eccentric muscle action rather than concentric muscle action, since eccentric muscle
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action produces greater loading of the elastic components. Usually eccentric exercise is
associated with negative effects, mainly muscle soreness. Muscle soreness leads to
strength reduction and myofibrillar damage, which usually recovers in healthy subjects
after prolonged eccentric training.29 Subjects with FM have a low level of a growth
hormone, somatomedin C, which may be linked to a lack of proper muscle tissue repair
for the microtraumas that occur constantly.30 Lack of proper muscle tissue repair and
muscle soreness may lead to reduced muscle strength in subjects with FM for concentric
and eccentric muscle actions. The combination of unhealthy muscle tissue and muscle
soreness occurring from greater loading of elastic components with eccentric muscle
action could be the reason why eccentric muscle action in this study was more
pronounced than concentric muscle action. Normally, peak torque tends to drop with
increasing velocity, while the drop in knee flexor torque has been found to be less than
that in the extensors. 31-32 Our study revealed less drop in peak torque of knee flexors than
extensors for only concentric muscle action in both groups.
We also focused on average power per percentage body weight for knee flexors
and extensors. We came to the conclusion that decreased muscle power for knee flexors
could be due to changes in connective tissue, which has been implicated by Smith.33
Severe damage and dissolution of myofilaments was observed under the electron
microscope. Researchers proposed that two tissues are affected in subjects with FM,
active skeletal muscles that react to nerve irritation by demonstrating pathologic changes
in muscle tissue in extensive areas of the body, and bradytrophic collagenous connective
tissue that reacts to lack of oxygen and overstrain by forming an excessive number of
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fibroblasts and dissolution of the collagen. 34-36
Collagen is a fibrous protein and a primary building block of connective tissue,
providing it with its high tensile strength and the ability to withstand load and
deformation. We related the decrease in muscle power to pathological connective tissue,
particularly collagen, in the knee muscles and periarticular (i.e capsule, ligament, fascia.
aponeurosis) tissues that surrounded the knee joint. Muscles and periarticular connective
tissue surrounding the knee joint must be able to deform in the time required for that
motion to take place. Unlike healthy subjects, the periarticular connective tissue of a
joint for subjects with FM may not have the ability to deform, or the ability of a muscle to
lengthen with increasing velocity. Therefore, it is reasonable to believe that muscle
power is decreased, since muscle power is produced with increased velocity.
Generally speaking, the more rapid the rate of deformation, the larger the peak
force, and the greater the tissues subsequent relaxation. We found a decrease in muscle
power compared to healthy subjects, not only at high speed of concentric muscle action
of the knee flexors, but also at low speed of eccentric muscle action of the knee flexors.
Our results also support the hypothesis of hypoxia and decreased content of high energy
metabolites,27'28 factors which cause a low relaxation rate, and help in producing power.
More studies need to focus on the relationship of power and tightness of the
connective tissue and differentiate between muscle strength and power in females with
fibromyalgia. Studying eccentric muscle action at different velocities and comparing it to
concentric muscle action is imperative to support our study. A comparison between knee
muscle flexors and extensors at different speeds for both muscle actions (concentric and
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eccentric) is important as well. Knee muscle strength, power, and total work was tested
only one time in this study. It would be beneficial, if further studies focused on testing
knee muscle strength, power, and total work after repeated measures.
An eccentric muscle action generates force at reduced oxygen cost and perceived
exertion compared to concentric muscle action,37 and changes in connective tissue have
also been implicated.38 Eccentric training improves the muscle capacity to store elastic
energy. The high stretching forces during eccentric contractions produce small structural
changes in type II muscle fibers.39,40 These adaptations produce an optimal overlay
between acing and myosin filaments as well as reduce the risk of injury to the muscle.40
Therefore, it is necessary for FM patients to perform a program with eccentric muscle
action at low speed to prevent the possibility of soft tissue injury and muscle soreness. It
is recommended that further studies focus on the possibility of increasing power using a
stretching program or eccentric muscle training. A biopsy of muscle tissue and
connective tissue may confirm the findings.
Conclusion
Our study supports the hypotheses that subjects with fibromyalgia demonstrate
decreased maximum muscle strength for knee flexors and extensors, and decreased
muscle power for knee flexors at different angular velocities, and different muscle action
compared to the control group. Isokinetic muscle strength parameters were considerably
lower by 18%-24% in the FM group compared to the healthy group. Average power was
significantly lower by 25%-30% compared to the healthy group. No differences in total
work at the two different velocities (607second and 1807second) and the two muscle
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actions (concentric and eccentric) were found.
In our study, the decreased muscle strength of knee flexors and extensors for
eccentric muscle action could be related to increased muscle soreness that was associated
with eccentric muscle action, since it produces greater loading of the elastic component
than concentric action. The lack of proper tissue repair from microtraumas and muscle
soreness may result in decreased muscle strength for subjects with FM for both muscle
actions (concentric and eccentric). The reduction in muscle power for knee flexors may
be related to pathological changes in muscle tissue and connective tissue in extensive
areas of the body, decreased muscle flexibility, and decreased energy metabolites.
Subjects with FM may not have as much ability of the periarticular connective tissue to
deform, or the ability of muscle to lengthen as healthy subjects.
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APPENDIX 1
LITERATURE REVIEW
FIBROMYALGIA:
GENERAL CONSIDERATIONS RELATED TO THE STUDY

Fibromyalgia syndrome (FMS), known previously as fibrositis, has emerged from
being a vague controversial disorder to an accepted diagnosis.1"3 FMS is a recognized
chronic musculoskeletal pain disorder of unknown etiology.4 The current estimate is that
3 to 6 million people in the United States have been diagnosed with FMS. It accounts for
4%-20% of new patients. 1,5-7 FMS is a disorder of young and middle aged women and is
the second or third most common diagnosis in rheumatology practices. 1,4
In 1990, the Copenhagen Declaration established fibromyalgia as a diagnosis.
The American College of Rheumatology has published the results of a large multi-center
study to indentify diagnostic criteria for the syndrome. These criteria were shown to have
high sensitivity and specificity.9 FMS is a diagnosis of exclusion. All other possible
etiologies and associated disease processes must be excluded by the test of time.
laboratory studies, radiologic studies, and surgical or exploratory procedures.10 To date,
no entities has been identified as the causative agent of FMS; many such as virus,
bacteria, neuroendocrine dysfunction and amplification, psychoendocrine dysfunction
and amplification,710 autonomic nervous system dysfunction,11 or central nervous system
deficiency,12 have been hypothesized.
Investigators have studied a variety of pathophysiologic mechanisms, including
sleep disturbance, psychological dysfunction, and muscle abnormalities.4 Investigators
25
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have focused on the histology and pathology of the tender point tissues. Tender points
occur in greater numbers in patients with FMS than in normal controls. 13,14 The tender
points are not specifically different, however, differences in immunoglobulin, cytokine.
tissue metabolism, capillary permeability, substance P levels, and interleukin-2 are
significant enough to suggest immunologic changes.14 Severe damage and dissolution of
myofilaments has been observed under the electron microscope, however, light
microscopy research has not shown any evidence of an inflammatory process in either the
muscle or the tendon tissues.13,16,17
Researchers proposed that two tissues are affected in FMS: (1) Active skeletal
muscles that are made up of cells that require a large amount of oxygen, and (2)
bradytrophic collagenous connective tissue requiring little oxygen. Each of these reacts
in different ways. The active oxygen-hungry skeletal muscle reacts to nerve irritation by
demonstrating pathologic changes in muscle tissue in extensive areas of the body,
whereas, the connective tissue reacts to a lack of oxygen and overstrain by forming an
excessive number of fibroblasts and dissolution of the collagen. 15,17,18
Bennett et al19 indicate that patients with fibromyalgia have significantly lower
serum levels of somatomedin C than do healthy controls. The rationale for measuring
somatomedin C levels in their study was based on theoretical considerations that 80% of
growth hormone is produced during stage-4 sleep. It was hypothesized that the
alpha/delta sleep anomaly, which occurs during 60% of stage-4 sleep in patients with
fibromyalgia, would disrupt the nocturnal secretion of growth hormone.20 The
physiologic link between disrupted stage-4 sleep and musculoskeletal pain has been
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obscure, but it was suggested that growth hormone is an anabolic peptide which
stimulates increased synthesis of DNA, RNA, and proteins; this effect is mediated via its
stimulation of somatomedin C secretion of the liver.21,22 It was hypothesized that, in some
patients with fibromyalgia, persistent disruption of growth hormone secretion as a result
of reduced anabolic stimulation due to low levels of somatomedin C, either predisposes
to muscle microtraumas or impairs the normal healing of muscle microtraumas that cause
increased pain after exertion. 23-25
Jacobsen et al26 found decreased maximum voluntary isokinetic contractions of
the right quadriceps muscle for subjects with fibromyalgia compared to healthy subjects.
They suggest that reduced maximum voluntary muscle strength is due to pain inhibition
on a conscious level or unconscious level. This may be partly responsible for this
finding. It has been shown, that subjects with fibromyalgia have increased levels of
substance P (neuropeptide), which is involved in pain transmission of peripheral
nociceptive stimuli from neural dorsal root fibers to the brain. Higher levels of substance
P are linked to sadness, inner tension, concentration difficulties, pain, and memory
disturbance.27 There is also evidence of reduced amino acid tryptophan, which is the
precursor of serotonin. When serotonin is depleted, there is a decrease in non-repetitive
eye movement (NREM) sleep and an increase in somatic complaints, and depression.28
A study by Jeschonneck et al29 demonstrated an increased concentration of erythrocyte,
decreased erythrocytes velocity, and a consequent decrease in the flux of erythrocytes in
the skin above the tender points, which supports the hypotheses that FM is related to local
hypoxia in the skin above tender points.
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Maquet et al30 report decreased maximal concentric isokinetic muscle strength of
the knee flexors in the FMS group more marked during aerobic than during anaerobic
exercise, due to changes in energy supply processes and not to pain. Curve characteristics
recorded in their study by an isokinetic dynamometer were satisfactory, denoting the
absence of major nociceptive phenomena. Nordenskiold et al31 determined that patients
with FMS had greatly reduced grip force, on average 40% of the control group. A study
by Norregaard et al32 showed that patients with FMS exhibited significant reduction in
voluntary muscle strength of the knee and elbow flexors and extensors of the order of
20%-30%. They found a low degree of effort, but near normal physical capacity, in the
fibromyalgia group. They could not attribute the low effort to psychopathology, as
measured by psychometric scoring.
Borman et al33 examined the muscle performance, isokinetic muscle strength,
muscle endurance ratio, and submaximal aerobic performance in patients with FMS. He
evaluated the relation between muscle performance, pain severity, clinical findings, and
physical activity level, and compared the results with healthy control subjects. Patients
and controls underwent an examination of isokinetic muscle strength of the right
quadriceps on a Cybex dynamometer, and submaximal aerobic performance tests were
done for all subjects. In their study, they found that maximal voluntary muscle strength
of the quadriceps was significantly lower in patients with FMS compared with the control
subjects. Endurance ratios showing the work capacity were not statistically different
between the two groups. Submaximal aerobic performance scores were higher in the
control group. There was no relationship between muscle performance and clinical
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findings, including pain severity, number of tender points, and duration of the symptoms
of FMS. They found a reduced quadriceps muscle strength and submaximal aerobic
performance in patients with FMS, indicating that patients have impaired muscle
function. Lindh et al34 studied maximal voluntary muscle contraction in patients with
fibromyalgia. They evaluated the possibility of reaching a higher muscular performance
by the use of superimposed electrical stimulation. The tests mainly involved kneeextension using a KIN KOM dynamometer. The patients in their study showed a
markedly reduced maximal voluntary contraction, but superimposed electrical stimulation
revealed submaximal values. The rationale for the reduced voluntary maximal
performance was an impaired control mechanism at a supraspinal level. The present
study supported the findings of all previous studies.30'34 Not only did we find decreased
knee muscle strength, but also, decreased power in females with FMS compared to
healthy females. This may be due to muscle soreness from unhealed microtraumas, slow
deformation of collagen and periarticular connective tissue of the knee joint, hypoxia, or
decreased content of high energy metabolites.

APPENDIX 2
INTRODUCTION TO ISOKINETICS IN REHABILITATION
The term Isokinetic describes a process in which a body segment accelerates to
achieve a pre-selected fixed speed against an accommodating resistance. Regardless of
how much force is exerted by the patient, segment angular velocity will not exceed the
pre-selected speed. As torque is produced in an attempt to overcome the pre-selected
speed, the resistance varies to exactly match the force applied at every point in the range
of motion. The amount of force applied by the patient can be measured in foot-pounds or
Newton-meters of torque and is represented both numerically and graphically. Cybex
isokinetic testing can be used to identify and quantify functional musculoskeletal deficits.
Since isokinetic resistance accomodates perfectly to the patient’s torque output, the risk
of overloading a tested joint is greatly minimized. Thus, Cybex isokinetic testing can be
used as a basis for comparison of test results. Any reduction in force output due to pain or
weakness results in an immediate reduction in resistance.
Many clinicians administer isokinetic tests and rehabilitation sessions over a
velocity spectrum in which slow, intermediate, and high-speed repetitions are performed.
This allows a wide range of data to be collected and examined. The slow speed test
provides a good indication of the patient’s ability to withstand compressive forces. It also
produces the best interpretation of torque curve shape. This testing speed provides the
best information of peak torque/body weight and agonist/antagonist ratios.
The importance of intermediate and high-speed testing and rehabilitation sessions lies in
their ability to provide a more accurate measure of each muscle group’s energy producing
30
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capability. It has been demonstrated that concentric testing at high speed will cause
patients to produce lower peak torque and work rates, but higher average power. Thus,
intermediate and high-speed testing provide a better indication of muscular capability at
functional speeds.
Benefits of IsokineticTraining
The maximal force developed by a muscle is related to its cross-sectional area.35
After the first few weeks of strength training, measurable improvements can be seen
before muscle hypertrophy is seen. The improvements are mainly due to neural
adaptations.36 During strength training, there is increased neural activation, which is
associated with improved synchronization of motor units, an increase in the number of
active motor units, and their rate of firing.37 Muscle biopsies show a significant increase
in the number of type II muscle fibers and area, although overall fiber area did not
increase.38 Significant increases in muscle glycolytic and mitochondrial and enzyme
activity were found.39
General Terms and Definitions
Isokinetic Mode
Isokinetic testing involves a dynamic preset fixed angular velocity with
accommodating resistance varying exactly in response to the force applied by the
individual throughout a specific range of motion.
Isometric Mode
Isometric testing involves contraction against a static preset angular velocity of
O /second with accommodating resistance. Strength is measured as the peak force or
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torque developed during a maximal voluntary contraction.
Isotonic Mode
Isotonic testing involves variable speed of movement with fixed resistance, such
as the use of free weights or machines. Isotonic exercises consist of concentric and
eccentric actions.
Types of Muscle Contraction
Concentric Action
In concentric muscle actions, force is developed through the muscle while the
distance between the origin and the insertion of the muscle becomes shorter. The force
developed depends on the muscle tension required to move the load, which varies with
joint position.
Eccentric action
In eccentric actions, the muscle lengthens while developing force, and the distance
between the origin and the insertion increases. The muscular force developed is
overcome by an opposing external force, and the muscle merely provides active resistance
as the opposing force stretches it to a more lengthened position. Eccentric actions
generate greater muscular tension and require less muscle work than concentric actions.
Eccentric action can be associated with delayed onset of muscle soreness,40 possibly due
to mechanical and biochemical causes. Eccentric muscle action involves tissue swelling
followed by disruption of the extracellular matrix, as a result of muscle injury, producing
pain and inflammation. Biochemical mechanisms involve the release of histamine,
kinins, and prostaglandins in response to tissue damage, leading to pain.41
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Isometric Action
In isometric, or static actions, the muscle acts to develop tension against a fixed
object or resistance. The distance between the origin and the insertion does not change.
and no movement of the lever arm occurs.
Muscle Strength and Related Terms
Strength (Torque)
Muscle strength refers to the capacity of a muscle to actively develop tension,
irrespective of the specific conditions under which this is measured. Clinical tests which
measure strength evaluate the capacity of a subject’s given muscle group to develop
maximum voluntary tension. The unit of measurement is Newton meters. Torque
decreases with increasing angular velocity of
movement.
Work
Work is the output of mechanical energy, or externally applied force, multiplied
by the distance through which it is applied. It is a useful measure of energy expenditure,
and it is expressed in Joules.
Power
Power refers to the rate of muscular work output. It is expressed in units of work
per unit of time. The unit of measure is Watts. It is an accurate indicator of the subject’s
actual work rate. Power increases with increasing test velocity.
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Peak Torque per Percentage Body Weight
Peak torque per percentage body weight is calculated by dividing the peak torque
for the speed by the subject’s body weight, and expressing it as a percentage.
Total Work per Percentage Body Weight
Total work per percentage body weigh is calculated by dividing the total amount
of work in joules for the listed speed by the subject’s body weight, and expressing that
value as a percentage.
Average Power per Percentage Body Weight
Average power per percentage body weight is calculated by dividing the average
power by the subject’s body weight, and expressing it as a percentage.

APPENDIX 3
CYBEX NORM ISOKINETIC DYNAMOMETER (CNID)42
The CNID is a single chair rehabilitation and testing system that collects accurate
data, and then compares the information to a database. The Cybex is designed to be
adaptable to patient needs as well as a clinician’s own treatment methods and ideas. The
Cybex provides anatomically correct positioning and positive stabilization for testing of
the musculature surrounding the shoulder, elbow, forearm, wrist, ankle, knee, and hip.
Test and exercise speeds ranging from 1 to 500 degrees per second are selectable as a
protocol requires. Range of motion is controlled by the computer and mechanical range
of motion stops. The high resolution, full color graphics display monitor may be used to
provide the patient with visual feedback. Over 1000 published articles and research
studies documented the safety, accuracy, and effectiveness of Cybex systems, while
providing a basis for comparison of test results.
Basic System Configuration and Specifications

Modes

Speeds/Sec

Torque

Concentric

5°-500o/Sec

500 ft. lbs. /678 Nm

Eccentric

5°-3007Sec

500 ft. lbs. /678 Nm

CPM

5°-3007Sec

500 ft. lbs. /678 Nm
500ft. lbs. / 678 Nm

Isometrics

35
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Computer (Domestic Configuration)
IBM- compatible 486 Dx2- 66 MHz
8 megabytes RAM
520+ megabytes formatted fast access hard disk drive
1.44 megabyte 3.5" floppy diskette
Extended keyboard with light pen input device
28.8 Kbps Internal Fax/Modem
Streamer tape back-up kit
Color printer
Graphics
High revolution super VGA 15" color graphic monitor
800 x 600 pixels resolution

Cybex Norm System Parts and Components
Refer to Figure 1 for the following different parts and components.
Electronics Enclosure
The electronics enclosure houses the system electronics, the computer, and an
optional uninterruptable power supply.
Comfort Switch
The comfort switch is handed to the patients at the start of a test or rehabilitation
session. If she feels any discomfort during the session, pressing the switch will
immediately abort the session and stop the machine.
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Dynamometer
The dynamometer is an integral part of the CNID. It measures the torque
produced by the patient. It provides controlled testing or exercise speeds from 0° to 500°
/second, and can withstand joint torques of up to 500 foot/pounds. The dynamometer’s
rotation, height, and tilt can be changed to properly position it for the testing or
rehabilitation pattern being used. For all standard patterns, the patient set-up window
displays “prompts” to help the clinician position the dynamometer, and also provides a
form to record the rotation, height, and tilt scale values.

Figure 1. Cybex Norm Isokinetic Dynamometer parts and components.
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Range Limiting System
The range limiting system provides computer controlled range of motion and
visible mechanical back up stops.
Monorail
The chair glides along the monorail for easy patient placement proximal to the
dynamometer. The monorail scale, located on both sides of the monorail, provides
reproducible placement of the chair pedestal.
Reclining Chair
The reclining chair assures stability during testing or rehabilitation sessions.
Multiple adjustment angles allow patients to be set-up in sitting, prone, or supine
positions for extremity testing or rehabilitation and provide the clinician with consistent
reproducible patient placement. The seat moves and provides the appropriate
stabilization of the torso, hips, waist, thighs, and the contralateral limb.
Grab Bar
Grab bars are strategically placed on the reclining chair’s seat and back to provide
anchor points for the thigh and torso stabilization belts, to provide “handles” to facilitate
proper positioning of the system by the clinician, and to provide stabilization grips to the
patient during the session.
Stabilization System
The stabilization system consists of a seat belt, double shoulder belts, thigh
stabilization belt, handle bars and grab bars, contralateral limb stabilizer for the knee,
thigh stabilization pad, and the reclining chair. The CNID is important because it helps
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prevent muscle substitutions while allowing the patient to be tested in a safe, comfortable
and anatomically correct position.
Swivel Monitor Arm with Keyboard and Monitor
The swivel monitor arm allows easy access to the keyboard and monitor from
either side of the chair. The keyboard and monitor can be turned away from the patient
during testing or positioned to face the patient during a rehabilitation session to provide a
motivational display.
Light Pen
A light pen is used as the point-and-click input device with the CNID application.
Printer
A printer provides a hard copy record of the patient’s test or rehabilitation session
data. All printing is done through the Windows print manager.
Testing of the Knee Joint
Biomechanical Consideration
Anatomical landmarks of the knee are palpated so that the axis of rotation for
testing is readily located. The mixed gliding and rocking motion of the knee joint in
extension/flexion causes this axis to shift slightly as the tibial plateau slides anteriorly
during extension and posteriorly during flexion. This small shift, however, has no
significant effect on the patient’s torque production.
Most frequently, anatomical problems presented in knee testing deal with patient
comfort or normal hyperextension of the joint. While it is desirable to maximally
stabilize the thigh in extension/flexion, insufficient padding underneath the thigh or
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securing the thigh belt too tightly can cause enough discomfort to inhibit force output.
The degree of hyperextension in a knee test is affected by the test speed. At slow
test speeds, no hyperextension may be noticeable. At higher test speeds, the inertia of the
limb tends to help the contracting muscles overcome the passive resistance of skin, fascia,
and articular structures so that significant hyperextension may occur. It is also possible
for the thigh to slightly lift off the chair during high speed testing.
These factors have no significant effect on torque measurements except during the
first one-eighth second of a high-torque contraction, during which the limb compresses
the foam padding of the reclining chair and shin pad, and takes up slack in the thigh belt.
They can combine, however, to produce errors relative to the position angle depending on
the force and direction of movement. This degree of error occurs only in the knee
extension/flexion test. It is considered acceptable in clinical applications because the
overall range of motion measurement is quite accurate and the position of any specific
torque measurement can be closely identified.
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